Phospholipid-binding properties of calphobindin-II(annexin VI), anticoagulant protein from human placenta. 1991

H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
Tokyo Research Laboratories, Kowa Co., Ltd., Japan.

Calphobindin-II (CPB-II, annexin VI), is a calcium dependent phospholipid binding protein that can be classified as a member of the annexin family. The phospholipid-binding properties of CPB-II were investigated by measuring the binding constants of [125I]-CPB-II using phospholipid vesicles consisting of 80% phosphatidylcholine and 20% phosphatidylserine. A dissociation constant (Kd) of CPB-II with the phospholipid vesicles was determined to be 0.2 to 0.3 nM in the presence of Ca2+ ranging from 0.3 to 30 mM. The number of CPB-II capable of binding to the phospholipid vesicles at 0.3 mM Ca2+ decreased to about 1/2 in the presence of Ca2+ of more than 1 mM. Prothrombin and factor X were effective in competing with the binding of CPB-II to the phospholipid vesicles, although their affinities were lower by two or three orders of magnitude than that of unlabeled CPB-II at 30 nM Ca2+. Competitive effects of CPB-II, calphobindin-I (CPB-I, annexin V) and calphobindin-III (CPB-III, annexin III) on binding of [125I]-CPB-II to phospholipid vesicles, were similarly observed.

UI MeSH Term Description Entries
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D002413 Cations, Divalent Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis. Divalent Cations
D005170 Factor X Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. Autoprothrombin III,Coagulation Factor X,Stuart Factor,Stuart-Prower Factor,Blood Coagulation Factor X,Factor 10,Factor Ten,Stuart Prower Factor,Factor X, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
January 1990, Journal of biochemistry,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
December 1992, The Tohoku journal of experimental medicine,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
April 1989, Rinsho byori. The Japanese journal of clinical pathology,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
December 1990, Thrombosis research,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
April 1992, The Tohoku journal of experimental medicine,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
December 1997, Biochimica et biophysica acta,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
August 1995, American journal of hematology,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
May 1989, The Journal of biological chemistry,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
October 1989, Nihon Sanka Fujinka Gakkai zasshi,
H Yoshizaki, and Y Hashimoto, and K Arai, and M Ohkuchi, and M Shiratsuchi, and Y Shidara, and M Maki
April 1998, The Journal of biological chemistry,
Copied contents to your clipboard!